Aluminium glycinate
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
![Ehealth DSI [Ehdsi V2.2.1] European Commission](http://data.docslib.org/img/264x/2d8312ad5214a07d6e0a1e4da92b67e4.webp)
Top View
- Atcveljavni 2014.Xlsx
- (12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
- Annex VII-A Substances and Related Substance Groups; Procurement Procedure Ref. EMA/2014/48/PH
- ( 12 ) United States Patent ( 10 ) Patent No.: US 10,675,278 B2 Arkenau -Mari? Et Al
- (12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
- Procurement Procedure Ref. EMA/2014/01/PH Annex VII-A Substances and Related Substance Groups
- How to Use Whodrug for Compliance with CM Domain in the CDISC
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- Klasifikacija ATC 2021
- Basic Aluminium Carbonate NOTE
- Pharmaceutical Composition Containing Ibuprofen and Aluminium Hydroxide
- Need to Irrational Drug Combinations
- ATC Code Title
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- WO 2009/092601 Al